Manufacturers therefore use these trends to introduce novel and innovative product lines that enable them to secure a solid foothold in the market. For example, in November 2020, Medtronic launched its InPenTM Intelligent insulin device with real-time guardianTM Connect CGM Data – the first intelligent insulin pen for diabetics with multiple daily injections. Recently, in April 2021, BioCorp and Roche Diabetes Care launched the Mallya smart insulin pen in France.
Key insights from FMI’s Smart Insulin Pens market report
- With connectivity, smart insulin pens connected via Bluetooth are expected to account for more than half of sales by 2031
- By indication, the treatment of type 2 diabetes accounts for the bulk of the use of smart insulin pens
- Retail pharmacies were the main distribution channels for smart insulin pens, and e-commerce sales soared
- US sees credible growth amid rising approval rates for new diabetes management devices
- Growing preference for needle-free insulin injections to increase uptake across the UK
- Germany and France should experience increased cooperation between key manufacturers in the long term
- Large concentration of manufacturers at regional level to fuel growth in India and China
Smart Insulin Pens Market – Key questions answered in the report
- What are the upcoming trends for the growth of the Smart Insulin Pens market?
- According to FMI, the global smart insulin pen market is likely to register a multi-billion dollar valuation in the short- and long-term projections due to an overall increase in the global population pool of diabetics and the consequent increase in hospital workloads. Demand for smart insulin pens with Bluetooth connectivity is expected to remain particularly high
- Which is the most promising market for smart insulin pens?
- According to FMI’s analysis, the demand for smart insulin pens across the US market is expected to remain high owing to the government’s incessant efforts to curb the diabetes epidemic due to…
[ad_2]
Source story
